Méhnyakrák: vizsgálatok itt: Kína
159 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleIparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT06878222 - 2. fázisCsak meghívásosEstablishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids
- Where
- Chongqing
- Életkor
- 18 év and over
- People
- 50
- Run by
- Chongqing University Cancer Hospital
See details and how to joinNCT06786780 - 2. fázisTaking peopleNeoadjuvant Immunochemotherapy in PD-L1-negative LACC
- Where
- Beijing, Changsha, Chengdu, Chongqing, Hangzhou, Hefei, Lanzhou, Nanning, Shenyang, Tianjin, Wuhan
- Életkor
- 18 év to 70 év
- People
- 40
- Run by
- Tongji Hospital
See details and how to joinNCT06288360 - No phaseNot yet taking people in KínaA Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Peking University Third Hospital
See details and how to joinNCT06882473 - No phaseNot yet taking people in KínactDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT06878196 - No phaseTaking peopleExploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 15
- Run by
- Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT06840418 - No phaseTaking peopleCervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood
- Where
- Wuhan
- Életkor
- 20 év to 60 év
- People
- 10 000
- Run by
- Zhongnan Hospital
See details and how to joinNCT06082765 - 2/3. fázisTaking peopleBAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 526
- Run by
- Bio-Thera Solutions
See details and how to joinNCT06123884 - No phaseCsak meghívásosEvaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Ding Ma
See details and how to joinNCT06810895 - 2/3. fázisCsak meghívásosA Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
- Where
- Linyi
- Életkor
- 18 év and over
- People
- 510
- Run by
- Shandong New Time Pharmaceutical Co., LTD
See details and how to joinNCT06755515 - 2. fázisNot yet taking people in KínaHerombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 30
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06745219 - 2. fázisNot yet taking people in KínaA Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 120
- Run by
- Tasly Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06724263 - No phaseNot yet taking people in KínaPredicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation
- Where
- Hangzhou
- Életkor
- 26 év to 54 év
- People
- 800
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT06713655 - 3. fázisTaking peopleA Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
- Where
- Beijing, Shanghai
- Életkor
- 18 év to 75 év
- People
- 420
- Run by
- Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06692166 - 2. fázisTaking peopleNeoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
- Where
- Guangzhou, Wuhan
- Életkor
- 18 év to 45 év
- People
- 40
- Run by
- Tongji Hospital
See details and how to joinNCT06289062 - 2/3. fázisTaking peopleNeoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
- Where
- Beijing, Changsha, Chengdu, Chongqing, Hangzhou, Hefei, Lanzhou, Nanning, Shenyang, Tianjin, Wuhan
- Életkor
- 18 év to 70 év
- People
- 440
- Run by
- Tongji Hospital
See details and how to joinNCT06288373 - 2. fázisTaking peopleStudy Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer
- Where
- Chongqing
- Életkor
- 18 év and over
- People
- 33
- Run by
- Chongqing University Cancer Hospital
See details and how to joinNCT05687851 - No phaseTaking peopleExploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer
- Where
- Fuzhou
- Életkor
- 18 év to 80 év
- People
- 200
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT06140589 - 2. fázisTaking peopleNeoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
- Where
- Jinan, Wuhan
- Életkor
- 18 év to 70 év
- People
- 50
- Run by
- Tongji Hospital
See details and how to joinNCT06289751 - 1. fázisTaking peopleSCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
- Where
- Qingdao
- Életkor
- 18 év and over
- People
- 18
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT06544720 - No phaseNot yet taking people in KínaA Prospective Cohort Study Comparing AI Prediction Model With Imaging Assessment to Diagnose Lymph Node Metastasis in Cervical Cancer
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 230
- Run by
- Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT06541288 - No phaseNot yet taking people in KínaThe Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
- Where
- Suzhou
- Életkor
- 18 év to 80 év
- People
- 80
- Run by
- Geneplus-Beijing Co. Ltd.
See details and how to joinNCT06283875 - 2/3. fázisTaking peopleTrans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Where
- Guanzhou
- Életkor
- 18 év and over
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT03755739 - 1/2. fázisTaking peopleTriplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 100
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05187338 - 3. fázisTaking peopleEvaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
- Where
- Liuzhou
- Életkor
- 20 év to 45 év
- People
- 8000
- Run by
- Shanghai Bovax Biotechnology Co., Ltd.
See details and how to joinNCT04422366